Osteolysis and cancer
Open Access
- 15 May 2001
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (10) , 1219-1220
- https://doi.org/10.1172/jci13073
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Osteoprotegerin inhibits prostate cancer–induced osteoclastogenesis and prevents prostate tumor growth in the boneJournal of Clinical Investigation, 2001
- The Molecular Basis of Osteoclast Differentiation and ActivationPublished by Wiley ,2001
- Cancer Cells Responsible for Humoral Hypercalcemia Express mRNA Encoding a Secreted Form of ODF/TRANCE That Induces Osteoclast FormationBiochemical and Biophysical Research Communications, 2000
- Interactions between Cancer and Bone Marrow Cells Induce Osteoclast Differentiation Factor Expression and Osteoclast-like Cell Formation in VitroBiochemical and Biophysical Research Communications, 2000
- Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1Endocrinology, 1999
- Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell Formation*Endocrinology, 1999
- Bisphosphonates in the Treatment of Malignant Bone DiseaseAnnual Review of Medicine, 1999
- Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.Journal of Clinical Investigation, 1996
- Quantitative Bone Histomorphometry in Humoral Hypercalcemia of Malignancy: Uncoupling of Bone Cell Activity*Journal of Clinical Endocrinology & Metabolism, 1982
- Direct resorption of bone by human breast cancer cells in vitroNature, 1978